Filing Details

Accession Number:
0001493152-21-007795
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-01 20:00:21
Reporting Period:
2021-03-15
Accepted Time:
2021-04-01 20:00:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876343 Lineage Cell Therapeutics Inc. LCTX Biological Products, (No Disgnostic Substances) (2836) 943127919
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1841756 Alexandra Hernandez 2173 Salk Avenue, Suite 200
Carlsbad CA 92008
Sr Director Finance/Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Acquisiton 2021-03-30 6,000 $0.69 6,000 No 4 M Direct
Common Shares, No Par Value Disposition 2021-03-30 6,000 $2.23 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Employee Stock Option (Right to Buy) Acquisiton 2021-03-15 42,700 $0.00 42,700 $2.43
Common Shares Employee Stock Option (Right to Buy) Disposition 2021-03-30 6,000 $0.00 6,000 $0.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
42,700 2031-03-15 No 4 A Direct
39,200 2030-03-17 No 4 M Direct
Footnotes
  1. One quarter of the options vest on March 15, 2022 and the balance vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.
  2. One quarter of the options vested on March 17, 2021 and the balance vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.